Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Dimethylcurcumin is a selective enhancer of androgen receptor (AR) degradation. By disrupting the interaction between AR and its coregulators, dimethylcurcumin directs the degradation of AR and reduces signaling through this receptor both in cultured cells and in animals.1,2,3 In this way, dimethylcurcumin suppresses the growth of hepatocellular carcinoma (HCC) cells both in culture and in mice.2 Dimethylcurcumin can be used to elucidate the consequences of signaling through AR in various cell types.1,4,5
WARNING This product is not for human or veterinary use.
1. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-
2. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 135(3), 947-955 (2008).
3. ASC-
4. Targeting fatty acid synthase with ASC-
5. Sorafenib with ASC-
Selective modulation of the androgen receptor activation function-